NFG
APRE icon

Next Financial Group’s Aprea Therapeutics APRE Stock Holding History

Next Financial Group’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Sell
5
-562
-99% -$49.6K ﹤0.01% 2854
2021
Q3 		$58K Sell
567
-8
-1% -$727 ﹤0.01% 1351
2021
Q2 		$56K Sell
575
-13
-2% -$1.2K ﹤0.01% 1342
2021
Q1 		$60K Buy
+588
New +$68.6K 0.01% 1208

Other funds holding APRE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return

Next Financial Group's APRE Position: Q4 2021 in Review

Next Financial Group reduced its Aprea Therapeutics (APRE) stake by 99% in Q4 2021, selling an estimated $49.6K and leaving 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2854.

Next Financial Group first reported a position in APRE in Q1 2021 and has held it in 4 quarters since. The position peaked at $60K in Q1 2021. 41 funds tracked by Wall St. Rank hold APRE as of Q4 2021.

  • Next Financial Group held 5 shares of Aprea Therapeutics worth $0 as of Q4 2021.
  • Next Financial Group sold 562 Aprea Therapeutics shares in Q4 2021, an estimated $49.6K.
  • Aprea Therapeutics made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2854 holding.
  • Next Financial Group first reported a position in Aprea Therapeutics in Q1 2021 and has held it in 4 quarters since.
  • Next Financial Group's Aprea Therapeutics position peaked at $60K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.